Inspire Medical Systems, Inc.
INSP
$52.07
-$0.09-0.17%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.60% | 16.81% | 22.05% | 27.11% | 28.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.60% | 16.81% | 22.05% | 27.11% | 28.49% |
| Cost of Revenue | 8.33% | 15.72% | 24.97% | 27.10% | 27.35% |
| Gross Profit | 14.55% | 17.01% | 21.53% | 27.12% | 28.70% |
| SG&A Expenses | 17.94% | 17.96% | 16.29% | 15.28% | 17.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.30% | 13.99% | 13.88% | 13.40% | 15.28% |
| Operating Income | 41.21% | 172.13% | 389.66% | 238.41% | 189.60% |
| Income Before Tax | 12.39% | 40.36% | 589.12% | 612.11% | 393.65% |
| Income Tax Expenses | -1,712.56% | 86.03% | 124.92% | 224.87% | 296.47% |
| Earnings from Continuing Operations | 171.77% | 34.82% | 783.73% | 522.69% | 352.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 171.77% | 34.82% | 783.73% | 522.69% | 352.96% |
| EBIT | 41.21% | 172.13% | 389.66% | 238.41% | 189.60% |
| EBITDA | 52.26% | 168.37% | 598.11% | 278.03% | 213.92% |
| EPS Basic | 180.17% | 34.90% | 785.52% | 514.98% | 345.49% |
| Normalized Basic EPS | 22.43% | 62.67% | 636.41% | 602.47% | 384.87% |
| EPS Diluted | 189.20% | 36.16% | 852.96% | 493.41% | 332.77% |
| Normalized Diluted EPS | 25.21% | 63.97% | 671.93% | 576.78% | 371.00% |
| Average Basic Shares Outstanding | -1.32% | -0.31% | 0.58% | 1.20% | 1.58% |
| Average Diluted Shares Outstanding | -2.28% | -0.60% | 1.32% | 3.09% | 2.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |